Radiopharmaceuticals

Biotech News

AdvanCell Raises $315M to Expand Radiopharmaceutical Manufacturing
Approvals News

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options
Biotech Blogs

Radiopharmaceutical Manufacturing: Ratio Therapeutics on Why Location and Logistics Matter
Biotech News

PharmaLogic Expands Radiopharmaceutical Footprint With New Atlanta Facility

Reduce Supply Risk with RTSM Designs for Radiopharmaceutical Trials

June 03, 2026

Improving Radioligand Therapy Translation with Large Animal Studies

May 27, 2026
Business & Finance News

AstraZeneca Outlines $15B China Investment Plan Through 2030

Combination Strategies To Improve Radioligand Therapy Efficacy

March 25, 2026
Biotech News

Aktis Oncology IPO Backs Radiopharmaceutical Platform for Solid Tumors
Biotech Blogs

Engineering Next-Gen Radiopharmaceuticals for Precision and Safety

Accelerating Radiopharmaceutical Therapy with Translational Tools

November 14, 2025
Biotech Blogs

From Isotope to Impact: How Radiopharmaceuticals Are Changing Cancer Care

FIH Clinical Trial Planning for Radiopharmaceuticals: From IND to Patient Dosing

January 26, 2026
Life Science Spotlight

What Are the Best Strategies to Streamline Next-Gen AOC and RDC Programs From Lead Candidate Design to Manufacture?
Biotech Blogs

Targeting CNS Cancers with Precision Radiotherapeutics
Biotech Blogs

Xtalks Featured Member: James Eldridge, Senior Director, Global Drug Safety, Y-mAbs Therapeutics